Michael G Harrington
Overview
Explore the profile of Michael G Harrington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
4034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yassine H, Self W, Kerman B, Santoni G, Navalpur Shanmugam N, Abdullah L, et al.
Alzheimers Dement
. 2022 Dec;
19(3):1041-1066.
PMID: 36479795
Disturbances in the brain's capacity to meet its energy demand increase the risk of synaptic loss, neurodegeneration, and cognitive decline. Nutritional and metabolic interventions that target metabolic pathways combined with...
2.
Martinez A, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, et al.
Alzheimers Dement
. 2022 Apr;
19(2):391-404.
PMID: 35416404
We propose the hypothesis that small high-density lipoprotein (HDL) particles reduce the risk of Alzheimer's disease (AD) by virtue of their capacity to exchange lipids, affecting neuronal membrane composition and...
3.
Solomon V, Hafez M, Xian H, Harrington M, Fonteh A, Yassine H
J Alzheimers Dis
. 2022 Apr;
87(2):609-617.
PMID: 35367966
Background: Mechanistic studies in animal models implicate a role for saturated fatty acids in neurodegeneration, but validation of this finding in human studies is still lacking. Objective: We investigated how...
4.
Arakaki X, Hung S, Rochart R, Fonteh A, Harrington M
Neurobiol Aging
. 2022 Jan;
112:87-101.
PMID: 35066324
Synaptic dysfunctions precede cognitive decline in Alzheimer's disease by decades, affect executive functions, and can be detected by quantitative electroencephalography (qEEG). We used quantitative electroencephalography combined with Stroop testing to...
5.
Arechavala R, Rochart R, Kloner R, Liu A, Wu D, Hung S, et al.
Int J Psychophysiol
. 2021 Oct;
170:102-111.
PMID: 34666107
Electroencephalographic (EEG) alpha oscillations have been related to heart rate variability (HRV) and both change in Alzheimer's disease (AD). We explored if task switching reveals altered alpha power and HRV...
6.
Castor K, Dawlaty J, Arakaki X, Gross N, Woldeamanuel Y, Harrington M, et al.
Front Mol Neurosci
. 2021 Sep;
14:691733.
PMID: 34531722
Background: Lipids are a primary storage form of energy and the source of inflammatory and pain signaling molecules, yet knowledge of their importance in chronic migraine (CM) pathology is incomplete....
7.
Libowitz M, Wei K, Tran T, Chu K, Moncrieffe K, Harrington M, et al.
PLoS One
. 2021 Jul;
16(7):e0254332.
PMID: 34292973
We hypothesized that automated assessment of brain volumes on MRI can predict presence of cerebrospinal fluid abnormal ß-amyloid42 and Tau protein levels and thus serve as a useful screening test...
8.
Babiloni C, Arakaki X, Azami H, Bennys K, Blinowska K, Bonanni L, et al.
Alzheimers Dement
. 2021 Apr;
17(9):1528-1553.
PMID: 33860614
The Electrophysiology Professional Interest Area (EPIA) and Global Brain Consortium endorsed recommendations on candidate electroencephalography (EEG) measures for Alzheimer's disease (AD) clinical trials. The Panel reviewed the field literature. As...
9.
Asanad S, Felix C, Fantini M, Harrington M, Sadun A, Karanjia R
Sci Rep
. 2021 Mar;
11(1):6344.
PMID: 33737516
The current study evaluated retinal function using electroretinography (ERG) in cognitively healthy (CH) participants with preclinical Alzheimer's disease (AD), as classified by cerebral spinal fluid (CSF) Aβ/Tau ratio. Individuals with...
10.
Cowan R, Gross N, Sweeney M, Sagare A, Montagne A, Arakaki X, et al.
Headache
. 2021 Mar;
61(3):536-545.
PMID: 33724462
Objective: Our objective is to explore whether blood-cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls. Background: Reports of blood-brain barrier and blood-cerebrospinal...